Winlevi Wins Approval: Cosmo's Stock Jumps

Cosmo Pharma stock surges as EU approves Winlevi acne treatment! The clascoterone cream is now greenlit for acne vulgaris in adults and teens, with a focus on facial treatment for adolescents. Following a positive expert recommendation, this approval signals a major market opportunity for Cosmo, but success now depends on patient response and doctor adoption.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.